I-Mab Biopharma
IMAB
#7064
Rank
HK$4.15 B
Marketcap
HK$36.04
Share price
-0.22%
Change (1 day)
341.22%
Change (1 year)

Revenue for I-Mab Biopharma (IMAB)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for I-Mab Biopharma from 2024 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
HK$1.75 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
HK$4.99 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA